• Trevi Therapeutics, Inc. (NASDAQ:TRVI) Receives Average Rating of "Buy" from Analysts

    Source: Buzz FX / 21 Feb 2025 03:26:12   America/Chicago


    Trevi Therapeutics, Inc. (NASDAQ:TRVI) Receives Average Rating of "Buy" from Analysts Written by MarketBeat February 21, 2025 Share Link copied to clipboard. Trevi Therapeutics, Inc. ( NASDAQ:TRVI - Get Free Report ) has been given a consen
    Read more...
Share on,